In this whitepaper, experts discuss how PET imaging is critical in determining response assessments in hematology trials and what to do when PET scans are not always available.

Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

  • This field is for validation purposes and should be left unchanged.